A Comprehensive Review of Deflazacort with Special Reference to Pharmacological Profile and Pharmaceutical Validation Processes

Abstract

Deflazacort is a prednisolone-derived immunosuppressant and anti-inflammatory. It controls cytokines and immune cell development. It may increase muscle cell proliferation and reduce muscle breakdown to enhance Duchenne muscular dystrophy muscle strength and function. Pharmaceutical companies aim to produce high-quality drugs at low prices. Pharmaceutical formulation discovery, development, and evaluation require validated methods. Validation ensures quality and reliability throughout the manufacturing process. The validation procedure evaluates accuracy, specificity, precision, and system applicability to guarantee the analytical technique used to analyze medicine-related samples is reliable. This paper describes the deflazacort technique development and validation. Google Scholar, Pub-Med, and Shodganga are utilized to gather information.